Why FDA Compliance Is Non-Negotiable
The United States dietary supplement market generates over $60 billion in annual revenue — but every product sold must comply with a complex web of federal regulations. For international brands, understanding these rules isn't optional; it's the difference between a successful launch and an FDA warning letter, import detention, or product recall.
This definitive guide covers every FDA requirement international supplement brands must meet before their first product reaches a U.S. consumer.
The Legal Framework: DSHEA and Beyond
The Dietary Supplement Health and Education Act of 1994 (DSHEA) established the regulatory framework for supplements in the U.S. Under DSHEA:
- No Pre-Market Approval: Unlike pharmaceuticals, dietary supplements do not require FDA approval before they are marketed — but they must be safe, properly labeled, and manufactured under cGMP conditions
- Manufacturer Responsibility: The burden of ensuring product safety and label accuracy falls on the manufacturer or distributor, not the FDA
- Post-Market Enforcement: The FDA monitors the market and can take action against products that are adulterated, misbranded, or make illegal claims
Current Good Manufacturing Practices (cGMP)
All dietary supplements sold in the U.S. must be manufactured under cGMP conditions as outlined in 21 CFR Part 111. Key requirements include:
- Identity Testing: Every incoming ingredient must be tested to verify its identity
- Specifications: Written specifications for identity, purity, strength, and composition of finished products
- Quality Control: Documented quality control procedures including in-process testing and finished product testing
- Record Keeping: Comprehensive batch records, testing records, and complaint files
- Personnel: Qualified personnel with adequate training in cGMP procedures
- Facility Standards: Clean, sanitary facilities with proper equipment maintenance
International brands manufacturing outside the U.S. must ensure their facilities meet these standards — FDA can and does inspect foreign manufacturing sites.
New Dietary Ingredient (NDI) Notifications
If your product contains a dietary ingredient that was NOT marketed in the U.S. before October 15, 1994, you must submit a New Dietary Ingredient (NDI) notification to the FDA at least 75 days before marketing. The notification must include:
- The name of the new dietary ingredient
- A description of the dietary supplement that contains the ingredient
- The level of the ingredient in the supplement
- The conditions of use
- Evidence of safety (history of use or other evidence establishing reasonable expectation of safety)
Facility Registration
Every facility that manufactures, processes, packs, or holds dietary supplements for U.S. consumption must:
- Register with the FDA under the Bioterrorism Act
- Renew registration biennially (even-numbered years, October 1 - December 31)
- Designate a U.S. Agent if the facility is located outside the United States
- Be subject to FDA inspection at any time
Adverse Event Reporting
Manufacturers, packers, and distributors must report serious adverse events to the FDA within 15 business days of receiving the report. You must also maintain records of all adverse event reports for 6 years.
Prohibited Ingredients and Adulterants
The FDA maintains a list of ingredients that are prohibited or subject to restrictions in dietary supplements. Products containing undeclared pharmaceutical ingredients (a common problem in weight loss, sexual enhancement, and bodybuilding supplements) are considered adulterated and subject to enforcement action.
Getting Started with Compliance
International brands should begin their FDA compliance journey well before their first shipment to the U.S. Start with a comprehensive product review, ensure manufacturing facilities meet cGMP standards, verify all ingredients are permissible, and invest in FDA-compliant labeling. NPI's team of regulatory experts can guide you through every step of this process.
Distribution Strategy
